相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma
Alexandrosz Czira et al.
RESPIRATORY MEDICINE (2022)
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma
Corrado Pelaia et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)
Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs
Carlyne M. Averell et al.
JOURNAL OF ASTHMA (2021)
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
Kenneth Chapman et al.
BMJ OPEN RESPIRATORY RESEARCH (2021)
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Laurie A. Lee et al.
LANCET RESPIRATORY MEDICINE (2021)
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
Satoru Inoue et al.
BMC PULMONARY MEDICINE (2021)
Corresponding doses of mometasone furoate (MF) in once-daily inhaled fixed-dose combination (FDC) of indacaterol/mometasone furoate (IND/MF) and indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF): results from randomized clinical studies
Roland Buhl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA
Hiromasa Inoue et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2021)
Inhaled steroid – Long acting beta two agonist (ICS–LABA) combinations in asthma: Are all formulations the same?
Rajesh Venkitakrishnan et al.
Indian Journal of Tuberculosis (2021)
Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study
Kenneth R. Chapman et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan
Hiroyuki Nagase et al.
ALLERGOLOGY INTERNATIONAL (2020)
Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings
Oliver Kornmann et al.
RESPIRATORY MEDICINE (2020)
Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
Shiyuan Zhang et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
Christian Gessner et al.
RESPIRATORY MEDICINE (2020)
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
Huib A M Kerstjens et al.
Lancet Respiratory Medicine (2020)
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects
Soniya Vaidya et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
Henrik Watz et al.
RESPIRATORY RESEARCH (2020)
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials
Johann Christian Virchow et al.
LANCET (2019)
Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids
Fabrizio Spada et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2018)
Assessment of osteoporosis using the FRAX method and the importance of vitamin D levels in COPD patients
Ceyda Anar et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2018)
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial
Richard W. Beasley et al.
BMJ OPEN (2015)
Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD
Lorraine Murphy et al.
DRUGS (2014)
Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
Huib A. M. Kerstjens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Salmeterol/Fluticasone Propionate A Review of its Use in Asthma
Kate McKeage et al.
DRUGS (2009)
Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children
Robert L. Cowie et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma
K. M. Beeh et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers
HS Nelson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
O Zetterström et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
分享论文
